Pharmacie Duval SRL
Pharmacie Duval reported total assets of 378,412 € at the end of the 2025 financial year (annual accounts filed with the NBB on 28 Aug 2026).
The score of Pharmacie Duval shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +31 % Total assets -6 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmacie Duval's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 15,039 € | ||||
| Equity | 76,581 € | ||||
| Cash | 30,059 € | ||||
| EBITDA | 48,143 € | ||||
| Total assets | 378,412 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
- Year ended 31 Dec 2024filed on 22 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
- Year ended 31 Dec 2021filed on 24 Jun 2022
Pharmacie Duval's financial analysis
- Solvency20.2%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmacie Duval
Pharmacie Duval's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0885.923.071
- VAT number
- BE0885923071
- Peppol
- Registered · 0208:0885923071 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Dec 2006
- Registered office
- 4800 Verviers
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmacie Duval (SRL) has been based in Verviers since 2006, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 15,039 € and equity of 76,581 €; its revenue is not published.
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharmacie Duval
Companies in the same business, of comparable size and area, outside its group.
- Apoteek SINT ROCHUS Retail sale of pharmaceutical products Halle · balance sheet 376,075 €
- P. Radoux Retail sale of pharmaceutical products Liège · balance sheet 381,087 €
- Koltfarma Retail sale of pharmaceutical products Charleroi · balance sheet 488,225 €
- Depouhon SPRLU Retail sale of pharmaceutical products Chastre · balance sheet 374,564 €
- Pintelon Retail sale of pharmaceutical products Oostkamp · balance sheet 373,225 €
- Family Pharma Retail sale of pharmaceutical products Brussels · balance sheet 372,644 €
- ParaPharmacie de Recogne Retail sale of pharmaceutical products Libramont-Chevigny · balance sheet 386,531 €
- Anfarma Retail sale of pharmaceutical products Antwerp · balance sheet 386,780 €
Frequently asked questions about Pharmacie Duval
What is the revenue of Pharmacie Duval?
Pharmacie Duval files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmacie Duval?
In Belgium, the VAT number is the company number prefixed with BE: BE0885923071 for Pharmacie Duval, if the company is VAT-registered. Its company number (CBE) is 0885.923.071.
Where is the registered office of Pharmacie Duval?
According to the CBE register, the registered office of Pharmacie Duval is in 4800 Verviers.
What is the equity of Pharmacie Duval?
At the close of the 2025 financial year, the equity of Pharmacie Duval amounts to 76,581 €, a solvency of 20.2% of total assets.
Who manages Pharmacie Duval?
The register lists 1 active mandates at Pharmacie Duval. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmacie Duval
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →